NextGen Patient Voice

In this episode, we explore the latest updates in healthcare and medical research. The CMS has proposed Medicare payment increases for skilled nursing facilities, hospices, inpatient rehabilitation, and psychiatric facilities for FY 2027, with a focus on enhancing quality reporting and oversight. The May 28, 2024 issue of JAMA highlights advancements in cardiovascular health, telemedicine, and mental health interventions. The AMGA partners with Talkiatry to improve psychiatric care access, while CMS announces participants in Medicare’s ACCESS Model. The New England Journal of Medicine reports on the use of CD19 CAR T-cell therapy for autoimmune hemolytic anemia, showing promise for broader autoimmune applications. Next-generation drug delivery technologies are advancing head and neck cancer treatment. Virtual trials are gaining traction, offering increased accessibility and efficiency. Tirzepatide shows potential in improving cardiovascular outcomes for type 2 diabetes patients. The Lancet discusses predictive models for rhabdomyolysis, enhancing clinical decision-making. Finally, targeted therapies in early phase clinical trials are advancing personalized cancer treatment.

Lucid Health Solutions Embedding the patient, caregiver and provider perspective into every decision that shapes health outcomes https://www.lucidhealthsolutions.com

Lucid Health Solutions Embedding the patient, caregiver and provider perspective into every decision that shapes health outcomes https://www.lucidhealthsolutions.com

📚 Sources:

What is NextGen Patient Voice?

NextGen Patient Voice explores how research, AI, and public policy are transforming patient advocacy. Each episode breaks down the ideas, tools, and decisions shaping the future of healthcare, with a focus on what they mean for patients, caregivers, and advocates. Clear, practical, and forward-looking, this podcast connects innovation to real-world patient impact.

[object Object]